SHOP APOTHEKE EUROPE N.V.: Stefan Feltens to strengthen management team with immediate effect; will succeed Michael Köhler, who will resign as chair of the managing board for personal reasons as of 31 December 2018.

DGAP-Ad-hoc: SHOP APOTHEKE EUROPE N.V. / Key word(s): Change of Personnel SHOP APOTHEKE EUROPE N.V.: Stefan Feltens to strengthen management team with immediate effect; will succeed Michael Köhler, who will resign as chair of the managing board for personal reasons as of 31 December 2018. 17-Sep-2018 / 20:38 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. SHOP APOTHEKE EUROPE N.V.: Stefan Feltens to strengthen management team with immediate effect; will succeed Michael Köhler, who will resign as chair of the managing board for personal reasons as of 31 December 2018. Venlo, 17 September 2018. The leading online pharmacy in continental Europe, SHOP APOTHEKE EUROPE N.V., is in the process of strengthening its management, in order to support its further European expansion. The supervisory board has affirmed the resolution of the managing board to appoint Stefan Feltens (54) as Manager of Purchasing and Human Resources with immediate effect and as CEO as of 1 January 2019. In this position, he will succeed Michael Köhler (55), who after 17 years with the company will resign as CEO effective 31 December 2018. Michael will continue to actively support Shop Apotheke Europe N.V. as consultant for international expansion and M&A. Stefan Feltens has many years of international experience in the pharmaceutical industry and until recently worked as Chief Financial Officer for Teva Global Operations, a division of the world's leading generics company, Teva Pharmaceuticals Industries Ltd., with annual sales of USD 20 billion. As a long-term shareholder of Europa Apotheek and current shareholder of SHOP APOTHEKE EUROPE N.V., he is familiar with SHOP APOTHEKE's online pharmacy business. In accordance with Dutch law, Stefan Feltens will be proposed to be appointed as a member of the managing board by the next general shareholders' meeting of SHOP APOTHEKE EUROPE N.V. This announcement contains forward-looking statements that are subject to certain risks and uncertainties. The future financial results can significantly differ from the currently anticipated results as a result of various risks and uncertainties, including changes in the business, financial and competitive landscape, uncertainties related to legal disputes or investigations and the availability of funds. SHOP APOTHEKE EUROPE assumes no obligation to update the forward-looking statements included in this announcement.   Contact: rikutis consulting Thomas Schnorrenberg Cel: [phone] E-Mail: [e-mail] Information and Explanation of the Issuer to this News: About SHOP APOTHEKE EUROPE SHOP APOTHEKE EUROPE is the leading and fastest growing online pharmacy in Continental Europe. With the acquisition of Europa Apotheek Venlo in November 2017, SHOP APOTHEKE EUROPE significantly extended its European market leadership with an expanded product range for the whole family in the areas of OTC, beauty and personal care products as well as prescription drugs. SHOP APOTHEKE EUROPE already operates online pharmacies in Germany, Austria, France, Belgium, Italy, Spain and the Netherlands. In Germany, the TÜV-certified shop-apotheke.com is the clear market leader. SHOP APOTHEKE EUROPE delivers a broad range of more than 100,000 original products to over 3 million active customers fast and at attractive prices. In addition, SHOP APOTHEKE EUROPE provides comprehensive pharmaceutical consulting services. SHOP APOTHEKE EUROPE N.V. has been listed on the regulated market of the Frankfurt Stock Exchange (Prime Standard) since 13 October 2016 and forms part of the SDAX since 24 September 2018.   17-Sep-2018 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de

Language:	English
Company:	SHOP APOTHEKE EUROPE N.V.
	Dirk Hartogweg 14
	5928 LV Venlo
	Netherlands
Phone:	0800 - 200 800 300
Fax:	0800 - 90 70 90 20
E-mail:	[e-mail]
Internet:	www.shop-apotheke-europe.com
ISIN:	NL0012044747, DE000A19Y072
WKN:	A2AR94, A19Y07
Listed:	Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange

End of Announcement	DGAP News Service

724463  17-Sep-2018 CET/CEST